YM443

DRUG3 trials

Sponsors

Astellas Pharma Inc

Conditions

DyspepsiaFunctional DyspepsiaIndigestionNausea

Phase 1

A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

CompletedNCT00850746

Astellas Pharma IncFunctional Dyspepsia

Start: 2009-02-28End: 2009-04-30Updated: 2014-03-24

Phase 2

YM443 in Subjects With Functional Dyspepsia

CompletedNCT00102310

Astellas Pharma IncIndigestion, Nausea

Start: 2004-03-10End: 2006-03-11Updated: 2018-01-10

Phase 3

A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia

CompletedNCT00764374

Astellas Pharma IncDyspepsia, Functional Dyspepsia

Start: 2008-08-31End: 2009-12-31Updated: 2014-10-29